That's very kind of you (but debatable).
IMO... Two years ago, the misalignment of management was our biggest risk. Today, our biggest risk is that T doesn't get the opportunity to 'prosecute' the Zantrene opportunity. That's what happens when you've got an ex-chair selling irrationally.
I really hope T (and the rest of the preclinical team) get the opportunity to knock this out of the park... but I'm doubtful. Zan has too many synergies in too many indications for everyone to sit on the sidelines waiting to see what happens.
General Comments / Chat, page-10143
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.055(3.59%) |
Mkt cap ! $260.7M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.60 | $1.53 | $79.91K | 51.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 23239 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |